Skip to content

Screener

Eligibility screening

OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

Sponsored by Ottimo Pharma LimitedStudy detailsClinicalTrials.gov

4 US sites in MA, MI, TX, UT

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.